MedWatch

Danish Merck collaboration is ahead of schedule

The Denmark-based biotech company, Nordic Bioscience, has completed enrollment of patients for a major phase II study conducted on behalf of German pharma giant Merck ahead of schedule – which makes the company hope for more.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Reuters: Kinesere vil købe J&J's diabetesforretning

Amerikanske Johnson & Johnson kan være på vej til at sælge sin forretning for diabetesudstyr for godt 24 mia. kr., efter flere kinesiske aktører ifølge Reuters har vist interesse i at overtage forretningsdelen.

Related articles